407 related articles for article (PubMed ID: 33152435)
1. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
Liu X; Wei F; Liu H; Zhao S; Du G; Qin X
J Ethnopharmacol; 2021 Mar; 268():113549. PubMed ID: 33152435
[TBL] [Abstract][Full Text] [Related]
2. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the compatibility rules of traditional Chinese medicine prescriptions based on NMR metabolomics: A case study of Xiaoyaosan.
Liu X; Lv M; Wang Y; Zhao D; Zhao S; Li S; Qin X
J Ethnopharmacol; 2020 May; 254():112726. PubMed ID: 32135241
[TBL] [Abstract][Full Text] [Related]
4. A combination of cecum microbiome and metabolome in CUMS depressed rats reveals the antidepressant mechanism of traditional Chinese medicines: A case study of Xiaoyaosan.
Lv M; Wang Y; Qu P; Li S; Yu Z; Qin X; Liu X
J Ethnopharmacol; 2021 Aug; 276():114167. PubMed ID: 33984458
[TBL] [Abstract][Full Text] [Related]
5. Brain metabonomics study of the antidepressant-like effect of Xiaoyaosan on the CUMS-depression rats by
Liu X; Zheng X; Du G; Li Z; Qin X
J Ethnopharmacol; 2019 May; 235():141-154. PubMed ID: 30708033
[TBL] [Abstract][Full Text] [Related]
6. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
Wu WZ; Ling-Hu T; Zhao YH; Zhao WD; Ji C; Tian JS; Ren Y; Qin XM
J Ethnopharmacol; 2023 Jan; 300():115702. PubMed ID: 36099982
[TBL] [Abstract][Full Text] [Related]
7. The synergistic anti-depression effects of different efficacy groups of Xiaoyaosan as demonstrated by the integration of network pharmacology and serum metabolomics.
Liu XJ; Wang YZ; Wei FX; Lv M; Qu P; Chen SJ; Li SY; Qin X
J Pharm Biomed Anal; 2021 Apr; 197():113949. PubMed ID: 33618131
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique.
Liu X; Liu C; Tian J; Gao X; Li K; Du G; Qin X
J Ethnopharmacol; 2020 Jan; 246():112219. PubMed ID: 31494201
[TBL] [Abstract][Full Text] [Related]
9. Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary (1)H NMR-based metabolomics.
Tian JS; Peng GJ; Gao XX; Zhou YZ; Xing J; Qin XM; Du GH
J Ethnopharmacol; 2014 Dec; 158 Pt A():1-10. PubMed ID: 25448502
[TBL] [Abstract][Full Text] [Related]
10. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
[TBL] [Abstract][Full Text] [Related]
11. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Gao X; Zheng X; Li Z; Zhou Y; Sun H; Zhang L; Guo X; Du G; Qin X
J Ethnopharmacol; 2011 Sep; 137(1):690-9. PubMed ID: 21718771
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomics reveals compatibility rules of the antidepressant effects of Xiaoyaosan and its efficacy groups.
Liu X; Wang Y; Lv M; Zhao S; Chen S; Li S; Qin X
Psychiatry Res; 2021 May; 299():113827. PubMed ID: 33676173
[TBL] [Abstract][Full Text] [Related]
13. Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression.
Li X; Qin XM; Tian JS; Gao XX; Du GH; Zhou YZ
J Ethnopharmacol; 2021 Jan; 264():113281. PubMed ID: 32810624
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome and tissue metabolomics reveal the compatibility effects of Xiaoyaosan on depression based on "gut-liver-kidney" axis.
Liu X; Wu X; Wang S; Qin X
Phytomedicine; 2023 Mar; 111():154628. PubMed ID: 36731299
[TBL] [Abstract][Full Text] [Related]
16. Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1Rβ/PI3K/Akt signaling pathway.
Zeng J; Ji Y; Luan F; Hu J; Rui Y; Liu Y; Rao Z; Liu R; Zeng N
J Ethnopharmacol; 2022 Apr; 288():115005. PubMed ID: 35051601
[TBL] [Abstract][Full Text] [Related]
17. Hepatic metabolomics of the compatibility effect of Xiaoyaosan on CUMS-induced depression based on the TCM theory of "Treating Diseases via Regulating the Liver's Function".
Liu XJ; Liu HL; Zhao D; Wei FX; Wang YZ; Lv M; Chen SJ; Li SY; Qin XM
J Pharm Biomed Anal; 2021 Jul; 201():114123. PubMed ID: 33989991
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and
Ruan X; Zhang X; Liu L; Zhang J
J Biomol Struct Dyn; 2024 Jul; 42(10):5128-5146. PubMed ID: 37440274
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of the fractions of Xiaoyaosan on rat model of chronic unpredictable mild stress.
Zhou Y; Lu L; Li Z; Gao X; Tian J; Zhang L; Wu B; Qin X
J Ethnopharmacol; 2011 Sep; 137(1):236-44. PubMed ID: 21640181
[TBL] [Abstract][Full Text] [Related]
20. Anti-depressive effects of Xiaoyaosan, Shugan and Jianpi herbal treatments: Role on the gut microbiome of CUMS rats.
Liu X; Lv M; Wang Y; Qu P; Li S; Yu Z; Qin X
Phytomedicine; 2021 Jul; 87():153581. PubMed ID: 34091149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
